References
- Ahmed F. E., Thomas D. B. Assessment of the carcinogenicity of the nonnutritive sweetener cyclamate. Crit. Rev. Toxicol. 1992; 22(2)81–118, [PUBMED], [INFOTRIEVE]
- Austin M. J., Han Y. H., Povirk L. F. DNA sequence analysis of mutations induced by melphalan in the CHO aprt locus. Cancer Genet. Cytogenet. 1992; 64(1)69–74, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Brook J. D., Chandley A. C. Testing of 3 chemical compounds for aneuploidy induction in the female mouse. Mutat. Res. 1985; 157(2–3)215–220, [PUBMED], [INFOTRIEVE]
- Butchko H. H., Stargel W. W., Comer C. P., Mayhew D. A., Benninger C., Blackburn G. L., de Sonneville L. M., Geha R. S., Hertelendy Z., Koestner A., Leon A. S., Liepa G. U., McMartin K. E., Mendenhall C. L., Munro I. C., Novotny E. J., Renwick A. G., Schiffman S. S., Schomer D. L., Shaywitz B. A., Spiers P. A., Tephly T. R., Thomas J. A., Trefz F. K. Aspartame: review of safety. Regul. Toxicol. Pharmacol. 2002; 35(2)1–92, [CROSSREF], [CSA]
- Durnev A. D., Oreshchenko A. V., Kulakova A. V., Beresten N. F., Seredenin S. B. Clastogenic activity of dietary sugar substitutes. Vopr. Med. Khim. 1995; 41(4)31–33, [PUBMED], [INFOTRIEVE], [CSA]
- Ewertz M. Breast cancer in Denmark. Incidence, risk factors, and characteristics of survival. Acta Oncol. 1993; 32: 595–615, [PUBMED], [INFOTRIEVE]
- Ewertz M., Gill C. Dietary factors and breast‐cancer risk in Denmark. Int. J. Cancer 1990; 46: 779–784, [PUBMED], [INFOTRIEVE]
- Generoso W. M., Witt K. L., Cain K. T., Hughes L., Cacheiro N. L., Lockhart A. M., Shelby M. D. Dominant lethal and heritable translocation test with chlorambucil and melphalan in male mice. Mutat. Res. 1995; 345(3–4)167–180, [PUBMED], [INFOTRIEVE]
- Hagiwara A., Fukushima S., Kitaori M., Shibata M., Ito M. Effects of three sweeteners on the rat urinary bladder carcinogenesis initiated by N‐butyl‐N‐(4‐hydroxybuthyl)‐nitrosamine. Gann 1984; 75(9)763–768, [PUBMED], [INFOTRIEVE]
- Ishii H. Incidence of brain tumors in rats fed aspartame. Toxicol. Lett. 1981; 7(6)433–438, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ito N., Fukushima S., Shirai T., Hagiwara A., Imaida K. Drugs, food additives and natural products as promoters in rat urinary bladder carcinogenesis. IARC Sci. Publ. 1984; 56: 399–407, [PUBMED], [INFOTRIEVE]
- Jeffrey A. M., Williams G. M. Lack of DNA‐damaging activity of five non‐nutritive sweeteners in the rat hepatocyte/DNA repair assay. Food Chem. Toxicol. 2000; 38(4)335–338, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mace M. L., Jr, Daskal Y., Wray W. Scanning‐electron microscopy of chromosome aberrations. Mutat. Res. 1978; 52: 199–206, [PUBMED], [INFOTRIEVE]
- Maher T. J. Natural food constituents and food additives: the pharmacologic connection. J. Allergy Clin. Immunol. 1987; 79: 413–422, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Maron D. M., Ames B. N. Revised method for the Salmonella mutagenicity test. Mutat. Res. 1983; 113: 173–215, [PUBMED], [INFOTRIEVE]
- Molinary S. V. Preiclinical Studies of Aspartame in Non‐primate Animals. Aspartame, Physiology and Biochemistry, L. D. Stegink, L. S. Tiler, Jr. Marcel Dekker, New York 1984; 289–306
- Nowak C. Induction of chromosomal aberrations by hypotonic culture conditions is dependent of the S‐phase in V79 hamster cells. Environ. Mol. Mutagen. 1984; 13(1)44–49
- Nowak C. Studies on the ability of hypotonic solutions to induce chromosomal aberrations in V79 cells. Teratog. Carcinog. Mutagen. 1997; 7(6)515–525
- Olney J. W., Farber N. B., Spitznagel E., Robins L. N. Increasing brain tumors rates: is there a link to aspartame?. J. Neuropathol. Exp. Neurol. 1996; 55(11)1115–1123, [PUBMED], [INFOTRIEVE], [CSA]
- Ranney R. E., Oppermann J. A. A review of the metabolism of the aspartyl moiety of aspartame in experimental animals and man. J. Environ. Pathol. Toxicol. 1979; 2(4)979–985, [PUBMED], [INFOTRIEVE]
- Rothfus A., Schütz P., Bochum S., Volm T., Eberhardt E., Kreirenberg R., Vogel W., Speit G. Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res. 2000; 60: 390–394
- Sargentini N. J., Smith K. C. Mutagenesis by normal metabolites in Escherichia coli: phenylalanine mutagenesis is dependent on error‐prone DNA repair. Mutat. Res. 1986; 161(2)113–118, [PUBMED], [INFOTRIEVE]
- Schwartz G. R. Aspartame and breast and other cancers. West J. Med. 1999; 171: 300–301, [PUBMED], [INFOTRIEVE], [CSA]
- Seeberg A. H., Mosesso P., Forster R. High‐dose‐level effects in mutagenicity assays utilizing mammalian cells in culture. Mutagenesis 1989; 3(3)213–218
- Shephard E. E., Meier I., Lutz W. K. Alkylating potency of nitrosated amino acids and peptides. IARC Sci. Publ. 1991; 105: 383–387, [PUBMED], [INFOTRIEVE]
- Shephard S. E., Wakabayashi K., Nagao M. Mutagenic activity of peptides and the artificial sweetener aspartame after nitrosation. Food Chem. Toxicol. 1993; 31(5)323–329, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Speit G., Haupter S. On the mechanisms of differential giemsa staining of bromodeoxyuridine‐substituted chromosomes. II Differences between the demonstration of sister chromatid differentiation and replication patterns. Hum. Genet. 1985; 70: 126–129, [PUBMED], [INFOTRIEVE], [CROSSREF]
- The ministry of Agricultural of Turkey. Food Codex. Globus World Publications, Turkey 1997; 46–47
- Weihrauch M. R., Diehl V., Bohlen H. Künstliche Süβstoffe‐Haben sie ein kanzerogenes potential?. Med. Klin. 2001; 96: 670–675, [PUBMED], [INFOTRIEVE]